Sanofi CEO on breakthroughs in cancer research, COVID-19 vaccine development, and drug pricing

Sanofi CFO details earnings, COVID-19 vaccine outlook, and drug developmentПодробнее

Sanofi CEO on coronavirus vaccine development and the pressure 'to get it right'Подробнее

Covid vaccine will be available by the end of 2021: Sanofi CEOПодробнее

Sanofi Has Two Covid Vaccines in Clinical TrialsПодробнее

Sanofi CEO on two-pronged approach to developing Covid-19 vaccineПодробнее

Sanofi CEO Paul Hudson on the coronavirus, the FDA, drug development and moreПодробнее

Sanofi CEO Paul Hudson on COVID-19 and potential vaccine (Full Stream 11/10)Подробнее

Sanofi CEO Paul Hudson on cancer research, Covid-19 vaccine and moreПодробнее

Sanofi CEO: Real breakthrough in RSV treatment is 'right around the corner'Подробнее

Sanofi: Our vaccine could serve as an excellent booster shotПодробнее

This is Nicolas’ SanofiПодробнее

'If we can play a part, we will be there' in Covid protection, says Sanofi's Paul HudsonПодробнее

Sanofi boss backtracks on US vaccine promise after criticism | Money TalksПодробнее

Sanofi Pasteur’s legacy: Over 45 years of advancing meningococcal disease protectionПодробнее

Sanofi CEO Paul Hudson: We've got perhaps the world's best immunology pipelineПодробнее

Sanofi seeks more cost cutsПодробнее

Sanofi – Our oncology ambitionПодробнее

Sanofi halts development of its Covid mRNA vaccineПодробнее

Developing COVID-19 Vaccines: Behind the ScenesПодробнее